PFM
EW icon

Premier Fund Managers’s Edwards Lifesciences EW Stock Holding History

Premier Fund Managers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-170,005
Closed -$12.1M – 176
2025
Q1 		$12.1M Buy
+170,005
New +$12.2M 0.45% 53
2024
Q4 		– Sell
-176,738
Closed -$11.8M – 195
2024
Q3 		$11.8M Buy
+176,738
New +$12.8M 0.42% 53
2024
Q2 		– Sell
-131,233
Closed -$12.5M – 207
2024
Q1 		$12.5M Buy
+131,233
New +$11M 0.49% 48
2021
Q1 		– Sell
-77,040
Closed -$6.91M – 230
2020
Q4 		$6.91M Sell
77,040
-4,780
-6% -$396K 0.3% 80
2020
Q3 		$6.41M Sell
81,820
-52,370
-39% -$4.09M 0.37% 78
2020
Q2 		$9.27M Buy
+134,190
New +$9.54M 0.58% 60

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Premier Fund Managers's EW Position: Q2 2025 in Review

Premier Fund Managers sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 170,005 shares — an estimated $12.1M sold.

Premier Fund Managers first reported a position in EW in Q2 2020 and held it in 6 quarters. The position peaked at $12.5M in Q1 2024. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Premier Fund Managers reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Premier Fund Managers sold 170,005 Edwards Lifesciences shares in Q2 2025, an estimated $12.1M.
  • Premier Fund Managers first reported a position in Edwards Lifesciences in Q2 2020 and held it in 6 quarters.
  • Premier Fund Managers's Edwards Lifesciences position peaked at $12.5M in Q1 2024.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Premier Fund Managers's 13F filing for Q2 2025, filed 11 Aug 2025.